Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.

[1]  Li Hai,et al.  Ascorbic acid-modified brain-specific liposomes drug delivery system with "lock-in" function. , 2019, Chemistry and physics of lipids.

[2]  Yong Wu,et al.  Liposomes actively recognizing the glucose transporter GLUT1 and integrin αvβ3 for dual‐targeting of glioma , 2019, Archiv der Pharmazie.

[3]  Yong Wu,et al.  Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation. , 2018, Bioorganic & medicinal chemistry.

[4]  Li Hai,et al.  GLUT1‐mediated venlafaxine‐thiamine disulfide system‐glucose conjugates with “lock‐in” function for central nervous system delivery , 2018, Chemical biology & drug design.

[5]  Huile Gao,et al.  Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability. , 2018, International journal of pharmaceutics.

[6]  Q. Mei,et al.  Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption. , 2017, Nanoscale.

[7]  Shuai Shi,et al.  Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone , 2017, International journal of nanomedicine.

[8]  Meng Xu,et al.  Efficacy and mechanism of action of etanercept in bone cancer pain. , 2017, Pharmazie.

[9]  A. Tong,et al.  Comparative study of (Asp)7-CHOL-modified liposome prepared using pre-insertion and post-insertion methods for bone targeting in vivo , 2017, Journal of drug targeting.

[10]  Zhirong Zhang,et al.  A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Dongsheng He,et al.  Synthesis and Preliminary Evaluation of Novel Bone-targeting NSAIDs Prodrugs based on Glutamic Acid Oligopeptides , 2015 .

[12]  R. Zhang,et al.  RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Li Hai,et al.  Design, synthesis and biological evaluation of brain targeting l-ascorbic acid prodrugs of ibuprofen with "lock-in" function. , 2014, European journal of medicinal chemistry.

[14]  Dongsheng He,et al.  Dual-targeting delivery system for bone cancer: synthesis and preliminary biological evaluation , 2012, Drug delivery.

[15]  K. Sakurai,et al.  Synthesis of calcium phosphate-binding liposome for drug delivery. , 2009, Bioorganic & medicinal chemistry letters.

[16]  Haifeng Liu,et al.  Bone-Targeting Anthraquinone-Diclofenac Prodrugs with Hydrolytic and Bone Affinity Characteristics , 2009 .

[17]  S. Sarig.  Aspartic acid nucleates the apatite crystallites of bone: a hypothesis. , 2004, Bone.